BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun XY, Yu SZ, Zhang HP, Li J, Guo WZ, Zhang SJ. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma. Cancer Med 2020;9:2868-78. [PMID: 32068352 DOI: 10.1002/cam4.2921] [Cited by in Crossref: 17] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Qian B, Lin H, Lan T, Li M, Wu X, Lin S, Song Z, Shen S, Peng B. Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinoma. World J Surg Oncol 2022;20:252. [PMID: 35932027 DOI: 10.1186/s12957-022-02681-4] [Reference Citation Analysis]
2 Zhang B, Tang B, Lv J, Gao J, Qin L. Systematic analyses to explore immune gene sets-based signature in hepatocellular carcinoma, in which IGF2BP3 contributes to tumor progression. Clin Immunol 2022;241:109073. [PMID: 35817291 DOI: 10.1016/j.clim.2022.109073] [Reference Citation Analysis]
3 Hou J, Wang Z, Li H, Zhang H, Luo L, Granito A. Immune-Related lncRNAs with WGCNA Identified the Function of SNHG10 in HBV-Related Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/9332844] [Reference Citation Analysis]
4 Zhao Y, Song Q, Xu F, Zhou Y, Zuo X, Zhang Z. Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma. Front Genet 2022;13:823443. [PMID: 35368686 DOI: 10.3389/fgene.2022.823443] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang J, Li Y, Zhang C, Chen X, Zhu L, Luo T. A hypoxia-linked gene signature for prognosis prediction and evaluating the immune microenvironment in patients with hepatocellular carcinoma. Transl Cancer Res 2021;10:3979-92. [PMID: 35116696 DOI: 10.21037/tcr-21-741] [Reference Citation Analysis]
6 Liu C, Wang S, Zheng S, Xu F, Cao Z, Feng X, Wang Y, Xue Q, Sun N, He J. Avoiding Absolute Quantification Trap: A Novel Predictive Signature of Clinical Benefit to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer. Front Immunol 2021;12:782106. [PMID: 34868057 DOI: 10.3389/fimmu.2021.782106] [Reference Citation Analysis]
7 Zhang X, Ping S, Wang A, Li C, Zhang R, Song Z, Gao C, Wang F. Development and Validation of an Immune-Related Gene Pairs Signature in Grade II/III Glioma. Int J Gen Med 2021;14:8611-20. [PMID: 34849006 DOI: 10.2147/IJGM.S335052] [Reference Citation Analysis]
8 Luo JP, Wang J, Huang JH. CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Biosci Rep 2021;41:BSR20211103. [PMID: 34405225 DOI: 10.1042/BSR20211103] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Wang H, Yu S, Cai Q, Ma D, Yang L, Zhao J, Jiang L, Zhang X, Yu Z. The Prognostic Model Based on Tumor Cell Evolution Trajectory Reveals a Different Risk Group of Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:737723. [PMID: 34660596 DOI: 10.3389/fcell.2021.737723] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Liu Y, Liu X, Gu Y, Lu H. A novel RNA binding protein-associated prognostic model to predict overall survival in hepatocellular carcinoma patients. Medicine (Baltimore) 2021;100:e26491. [PMID: 34398005 DOI: 10.1097/MD.0000000000026491] [Reference Citation Analysis]
11 Fu Y, Sun S, Bi J, Kong C, Yin L. A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer. BMC Cancer 2021;21:810. [PMID: 34266411 DOI: 10.1186/s12885-021-08486-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Liu J, Han F, Ding J, Liang X, Liu J, Huang D, Zhang C. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis. Biomed Res Int 2021;2021:8849415. [PMID: 34337056 DOI: 10.1155/2021/8849415] [Reference Citation Analysis]
13 He J, Fang X, Han M. Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma. Front Genet 2021;12:654657. [PMID: 34108990 DOI: 10.3389/fgene.2021.654657] [Reference Citation Analysis]
14 Fu Y, Sun S, Bi J, Kong C, Yin L. Construction and analysis of a ceRNA network and patterns of immune infiltration in bladder cancer. Transl Androl Urol 2021;10:1939-55. [PMID: 34159075 DOI: 10.21037/tau-20-1250] [Reference Citation Analysis]
15 Huo J, Wu L, Zang Y. Eleven immune-gene pairs signature associated with TP53 predicting the overall survival of gastric cancer: a retrospective analysis of large sample and multicenter from public database. J Transl Med 2021;19:183. [PMID: 33926488 DOI: 10.1186/s12967-021-02846-x] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
16 Wang S, Xu X. An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma. Front Oncol 2021;11:564960. [PMID: 33859933 DOI: 10.3389/fonc.2021.564960] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Cao J, Wu L, Lei X, Shi K, Shi L. A signature of 13 autophagy‑related gene pairs predicts prognosis in hepatocellular carcinoma. Bioengineered 2021;12:697-707. [PMID: 33622179 DOI: 10.1080/21655979.2021.1880084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
18 Luo Q, Vögeli TA. Reclassification of Kidney Clear Cell Carcinoma Based on Immune Cell Gene-Related DNA CpG Pairs. Biomedicines 2021;9:215. [PMID: 33672457 DOI: 10.3390/biomedicines9020215] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Wu C, Hu Q, Ma D. Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinoma. Sci Rep 2021;11:3611. [PMID: 33574499 DOI: 10.1038/s41598-021-83120-4] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
20 Tian S, Liu J, Sun K, Liu Y, Yu J, Ma S, Zhang M, Jia G, Zhou X, Shang Y, Han Y. Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma. Front Oncol 2020;10:597996. [PMID: 33575212 DOI: 10.3389/fonc.2020.597996] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
21 Li Y, Yao P, Zhao K, Ye Z, Zhang H, Cao J, Zhang S, Xing C. Individualized prognostic signature for pancreatic carcinoma validated by integrating immune-related gene pairs (IRGPs). Bioengineered 2021;12:88-95. [PMID: 33393862 DOI: 10.1080/21655979.2020.1860493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Xie R, Dong S, Jiang J, Yang C, Li L, Zhao S, Li Y, Wang C, Li S, Xiao Y, Chen L. Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma. Clin Cosmet Investig Dermatol 2020;13:973-86. [PMID: 33364806 DOI: 10.2147/CCID.S281364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Song J, Zhao Q, Xu Y, Zhu L. A signature of 29 immune-related genes pairs to predict prognosis in patients with neuroblastoma. Int Immunopharmacol 2020;88:106994. [PMID: 33182060 DOI: 10.1016/j.intimp.2020.106994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Zhou X, Qiu S, Jin D, Jin K, Zheng X, Yang L, Wei Q. Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma. Front Genet 2020;11:569884. [PMID: 33240321 DOI: 10.3389/fgene.2020.569884] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
25 Meng L, He X, Zhang X, Zhang X, Wei Y, Wu B, Li J, Xiao Y. Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein. Biomed Res Int 2020;2020:8896511. [PMID: 33195699 DOI: 10.1155/2020/8896511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Liu C, Chen B, Huang Z, Hu C, Jiang L, Zhao C. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer. Int Immunopharmacol 2020;89:107074. [PMID: 33049494 DOI: 10.1016/j.intimp.2020.107074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
27 Meng L, He X, Zhang X, Zhang X, Wei Y, Wu B, Li W, Li J, Xiao Y. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature. PLoS One 2020;15:e0240331. [PMID: 33031392 DOI: 10.1371/journal.pone.0240331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Zhang Q, Yu X, Zheng Q, He Y, Guo W. A Molecular Subtype Model for Liver HBV-Related Hepatocellular Carcinoma Patients Based on Immune-Related Genes. Front Oncol 2020;10:560229. [PMID: 33072587 DOI: 10.3389/fonc.2020.560229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 Sun XY, Yu SZ, Zhang HP, Li J, Guo WZ, Zhang SJ. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma. Cancer Med 2020;9:2868-78. [PMID: 32068352 DOI: 10.1002/cam4.2921] [Cited by in Crossref: 17] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]